US drugmakers fall as Trump threatens tariffs again

Shares of some U.S. drugmakers fall after U.S. President Donald Trump reiterated plans for a "major" tariff on all pharmaceutical imports as his "reciprocal" tariffs took effect

Trump had also threatened the duties on Friday, after his first set of "reciprocal" tariffs announced last week exempted pharma products

Shares of Gilead Sciences GILD.O, Eli Lilly LLY.N, Biogen BIIB.O, Pfizer PFE.N and Bristol Myers Squibb BMY.N fall between 1% and 4%

Shares of Amgen AMGN.O, Merck MRK.N, AbbVie ABBV.N, Johnson & Johnson JNJ.N decline between 1.5% and 2.2%

Brokerage BMO Capital Markets says the tariffs on pharmaceuticals will "likely do little to shift manufacturing back to the US" as the country already has robust biomanufacturing and fill-and-finish onshore

Up to last close, LLY down 5.9%, MRK down 20.6%, BIIB down 25.4%, AMGN up 7.5% and GILD up 11.7% YTD